Apex Biotechnology Corp (1733)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Apex Biotechnology Corp (1733) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011289
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and exports related products, parts and components. ApexBio’s products include glucose monitoring systems, uric acid monitoring systems, lactate monitoring system, hemoglobin monitoring system, cholesterol monitoring system, hemoglobin A1C POC system, pesticide residue quick check systems and care management and tele-health. The company operates through its manufacturing facilities in Hsinchu City and Taoyuan City in Taiwan. ApexBio is headquartered in Hsinchu, Taiwan.

Apex Biotechnology Corp (1733) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Apex Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Apex Biotechnology Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Apex Biotechnology Corp, Medical Equipment, Deal Details 10
Equity Offering 10
Apex Biotechnology Announces Public Offering Of Shares For US$6.5 Million 10
Debt Offering 11
Apex Biotech Raises USD12.8 Million in Public Offering of Bonds Due 2018 11
Acquisition 12
Apex Biotechnology Acquires 25% Stake In Omnis Health For US$10 Million 12
Apex Biotechnology Corp – Key Competitors 13
Apex Biotechnology Corp – Key Employees 14
Apex Biotechnology Corp – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Apex Biotechnology Corp, Medical Equipment, Key Facts, 2016 2
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Apex Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Apex Biotechnology Corp, Deals By Market, 2011 to YTD 2017 8
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Apex Biotechnology Announces Public Offering Of Shares For US$6.5 Million 10
Apex Biotech Raises USD12.8 Million in Public Offering of Bonds Due 2018 11
Apex Biotechnology Acquires 25% Stake In Omnis Health For US$10 Million 12
Apex Biotechnology Corp, Key Competitors 13
Apex Biotechnology Corp, Key Employees 14
Apex Biotechnology Corp, Other Locations 15

★海外企業調査レポート[Apex Biotechnology Corp (1733)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Coda Octopus Group Inc:企業の戦略・SWOT・財務情報
    Coda Octopus Group Inc - Strategy, SWOT and Corporate Finance Report Summary Coda Octopus Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tyson Fresh Meats Inc:企業の戦略・SWOT・財務情報
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alinma Bank:企業の戦略・SWOT・財務分析
    Alinma Bank - Strategy, SWOT and Corporate Finance Report Summary Alinma Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NeuroLogica Corp-医療機器分野:企業M&A・提携分析
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • HealthSouth Corporation:企業のM&A・事業提携・投資動向
    HealthSouth Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HealthSouth Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • Lanco Infratech Ltd (LITL):電力:M&Aディール及び事業提携情報
    Summary Lanco Infratech Ltd. (Lanco) is an integrated infrastructure enterprise that operates in diversified fields such as engineering, procurement and construction (EPC); operation and maintenance; and development. Through delivery partners in construction, civil, and electrical engineering, it of …
  • Tempur Sealy International, Inc.:企業の戦略・SWOT・財務情報
    Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CPFL Energia SA:企業の発電所・SWOT分析2018
    CPFL Energia SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Syngen Biotech Co Ltd (8279)-製薬・医療分野:企業M&A・提携分析
    Summary Syngen Biotech Co Ltd (Syngen), a part of Standard Chem& Pharm Co Ltd, is a biotechnology company that specializes in strain identification, micro-organism fermentation, recovery, and purification. The company research, develops, manufactures and distributes active pharmaceutical ingredients …
  • BMO Private Bank:企業の戦略・SWOT・財務情報
    BMO Private Bank - Strategy, SWOT and Corporate Finance Report Summary BMO Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Helen of Troy Ltd:企業の戦略・SWOT・財務情報
    Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report Summary Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Callon Petroleum Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Callon Petroleum Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exp …
  • Telephonics Corporation:企業の戦略的SWOT分析
    Telephonics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • LG Corp (003550):企業の財務・戦略的SWOT分析
    LG Corp (003550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SunPower Corporation:企業の戦略・SWOT・財務分析
    SunPower Corporation - Strategy, SWOT and Corporate Finance Report Summary SunPower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sto SE & Co KGaA:企業の戦略・SWOT・財務情報
    Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆